DIA Biosimilars 2013

CRF Health

CRF Health enhances its eCOA solutions

Tuesday, July 30, 2013 09:30 AM

CRF Health, an electronic Clinical Outcome Assessment (eCOA) solutions provider based in Plymouth Meeting, Penn., has announced several innovative enhancements to its TrialMax eCOA solutions. 

More... »

Cenduit: Now with Patient Reminders

CRF Health first to achieve Gold Standard of Juniper’s ACQ, AQLQ ePRO instruments on the TrialMax Platform

Monday, February 4, 2013 02:43 PM

CRF Health, the developer of the TrialMax Suite of electronic Clinical Outcome Assessment Solutions (eCOA) for the life sciences industry, became the first eCOA company to complete a full validation study for professor Elizabeth F. Juniper’s ACQ and AQLQ questionnaires to the “Gold Standard” based on her recently released “Levels of Acceptability of Electronic Versions” rating system.

More... »

CRF Health – eCOA Forum

CRF Health launches TrialMax Web for late-phase studies

Thursday, February 23, 2012 06:14 AM

CRF Health, a global provider of ePRO solutions, has launched TrialMax Web, an online ePRO and patient management solution for global late-phase clinical studies.

More... »

CRF Health reports growing revenue and earnings

Tuesday, August 2, 2011 10:43 AM

CRF Health has reported that the company’s revenues for the six month period more than doubled from the same period in 2010, while earnings showed an even larger percentage increase over the prior period. CRF Health has now consistently generated earnings over the last ten consecutive quarters. CRF Health also added more than 15 new sponsor or CRO relationships while retaining 100% of its key account client base during that time.  

More... »

CRF Health appoints John Larson as COO

Tuesday, May 10, 2011 12:08 PM

CRF Health, a global provider of ePRO solutions for the life sciences industry today has appointed John Larson to the position of chief operating officer.  In this role, John will be responsible for global operations and lead the client services, logistics and helpdesk functions. 

More... »

Lindevall Returns as CEO of Encorium

Friday, January 15, 2010 06:44 AM

CEO musical chairs continues at Wayne, Pa.-based contract research organization (CRO) Encorium . The company has reappointed Dr. Kai Lindevall as CEO, replacing David Ginsberg who left the company last summer when Encorium sold its U.S. business to Pierrel Research USA and Ginsberg became CEO there. Ginsberg had replaced Lindevall as CEO in September 2008. Lindevall, who replaced Kenneth Borow, M.D., as CEO in February 2008, has served as executive chairman since Ginsberg became CEO. Board member Shahab Fatheazam will serve as Encorium’s new chairman.  

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs